Dexlansoprazole is a proton pump inhibitor (PPI) widely used in the clinical management of gastroesophageal reflux disease (GERD) and the treatment of erosive esophagitis. It functions by irreversibly… Read more

![Chemical structure of (R)-2-(((1H-Benzo[d]imidazol-2-yl)sulfinyl)methyl)-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine 1-oxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1427429-03-5-R-2-1H-Benzodimidazol-2-ylsulfinylmethyl-3-methyl-4-222-trifluoroethoxypyridine-1-oxide.png&w=3840&q=75)
![Chemical structure of (R)-2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1-nitroso-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-2-3-Methyl-4-222-trifluoroethoxypyridin-2-ylmethylsulfinyl-1-nitroso-1H-benzodimidazole.png&w=3840&q=75)
![Chemical structure of (R)-2-(((3-Methyl-4-nitropyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F853950-77-3-R-2-3-Methyl-4-nitropyridin-2-ylmethylsulfinyl-1H-benzodimidazole.png&w=3840&q=75)

![Chemical structure of 2-(1H-Benzo[d]imidazol-2-yl)-2-(3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)-2H-benzo[d][1,3]thiazeto[3,2-a]imidazole](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-1H-Benzodimidazol-2-yl-2-3-methyl-4-222-trifluoroethoxypyridin-2-yl-2H-benzod13thiazeto32-aimidazole.png&w=3840&q=75)
![Chemical structure of 3-Methoxy-4-methylbenzo[4,5]imidazo[1,2-b]pyrido[1,2-d][1,2,4]thiadiazine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F102804-87-5-3-Methoxy-4-methylbenzo45imidazo12-bpyrido12-d124thiadiazine.png&w=3840&q=75)
![Chemical structure of 7-(3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)-7H-benzo[4,5]imidazo[2,1-b]benzo[4,5]imidazo[2,1-d][1,3,5]thiadiazine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1781244-56-1-7-3-Methyl-4-222-trifluoroethoxypyridin-2-yl-7H-benzo45imidazo21-bbenzo45imidazo21-d135thiadiazine.png&w=3840&q=75)



Dexlansoprazole is a proton pump inhibitor (PPI) widely used in the clinical management of gastroesophageal reflux disease (GERD) and the treatment of erosive esophagitis. It functions by irreversibly inhibiting the gastric hydrogen/potassium-ATPase enzyme system to reduce stomach acid production. Within this catalogue, the collection of Dexlansoprazole reference standards, impurities, and stable isotope-labelled compounds serves as an essential resource for pharmaceutical analysis. These high-quality materials are critical for laboratories engaged in rigorous quality control, impurity profiling, and the validation of analytical methods. By providing well-characterized degradation products and synthetic intermediates, these compounds enable researchers to accurately identify and quantify potential impurities, ensuring compliance with regulatory standards for drug potency, stability, and safety. Furthermore, stable isotope-labelled versions are utilized to enhance the precision of quantitative assays, supporting comprehensive stability studies throughout the drug development lifecycle.